Nuvation Bio (NUVB) Operating Expenses (2020 - 2026)
Nuvation Bio (NUVB) posted quarterly Operating Expenses of $79.3 million for Q1 2026, up 27.8% year-over-year from $62.1 million in Q1 2025, and down 5.45% quarter-over-quarter from $83.9 million in Q4 2025.
Nuvation Bio (NUVB) Operating Expenses (2020 - 2026) Analysis & Trends
Nuvation Bio (NUVB) has reported Operating Expenses for 7 consecutive years, with $79.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Expenses rose 27.8% year-over-year to $79.3 million; the TTM figure through Mar 2026 stood at $295.3 million (down 54.03% YoY), while the FY2025 annual figure was $276.0 million, down 54.04% from the prior year.
- Operating Expenses retreated to $79.3 million in Q1 2026 per NUVB's latest filing, from $83.9 million in the prior quarter.
- Across five years, Operating Expenses topped out at $470.5 million in Q2 2024 and bottomed at $20.2 million in Q1 2024.
- Historically, Operating Expenses has averaged $69.3 million across 5 years, with a median of $37.9 million in 2022.
- Annual changes were most pronounced in 2024 — Operating Expenses jumped 1700.44% — and 2025, when it tumbled 86.0%.
- Nuvation Bio's Operating Expenses stood at $24.3 million in 2022, then dropped by 14.4% to $20.8 million in 2023, then jumped by 200.11% to $62.5 million in 2024, then jumped by 34.24% to $83.9 million in 2025, then dropped by 5.45% to $79.3 million in 2026.
- Business Quant data shows NUVB's Operating Expenses at $79.3 million in Q1 2026, $83.9 million in Q4 2025, and $66.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Nuvation Bio | 2.16 Bn | 2.16 Bn | 30.78 Mn | 82.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 82.72 Mn |
| Mar 31, 2026 | 79.35 Mn |
| Dec 31, 2025 | 83.92 Mn |
| Sep 30, 2025 | 66.21 Mn |
| Jun 30, 2025 | 65.85 Mn |
| Mar 31, 2025 | 62.09 Mn |
| Dec 31, 2024 | 62.52 Mn |
| Sep 30, 2024 | 47.31 Mn |
| Jun 30, 2024 | 470.47 Mn |
| Mar 31, 2024 | 20.20 Mn |
| Dec 31, 2023 | 20.83 Mn |
| Sep 30, 2023 | 26.34 Mn |
| Jun 30, 2023 | 26.13 Mn |
| Mar 31, 2023 | 26.52 Mn |
| Dec 31, 2022 | 24.34 Mn |
| Sep 30, 2022 | 29.34 Mn |
| Jun 30, 2022 | 37.87 Mn |
| Mar 31, 2022 | 28.19 Mn |
| Dec 31, 2021 | 29.61 Mn |
| Sep 30, 2021 | 22.79 Mn |